Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Cancer
|
December 9, 2020
Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma
Mrinal M Gounder, Priscilla Merriam, Ravin Ratan, et al.
Rare Tumors
|
August 6, 2024
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort
Michael S Nakazawa, J Andrew Livingston, Maria A Zarzour, et al.
Practical Radiation Oncology
|
January 24, 2026
Outcomes Following Combined Modality Treatment to the Primary Site in Select Patients With Metastatic Soft Tissue Sarcoma
Andrew J Arifin, Andrew J Bishop, Devarati Mitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2023
Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes
Ryan A Denu, Richard K Yang, Alexander J Lazar, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 2023
SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection
Ahsan S Farooqi, Alison K Yoder, Heather Y Lin, et al.
Cancers
|
March 13, 2024
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?
Prapassorn Thirasastr, Thomas L Sutton, Cissimol P Joseph, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
April 25, 2025
Building a pre-surgical multiparametric-MRI-based morphologic, qualitative, semiquantitative, first and high-order radiomic predictive treatment response model for undifferentiated pleomorphic sarcoma to replace RECIST
Raul F Valenzuela, Elvis Duran-Sierra, Mathew Antony, et al.
Cancers
|
May 11, 2024
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience
Lewis F Nasr, Marianne Zoghbi, Rossana Lazcano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2022
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)
Justin T Moyers, Roberto Carmagnani Pestana, Jason Roszik, et al.
Journal of the National Cancer Institute
|
September 1, 2016
IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma
Salah-Eddine Lamhamedi-Cherradi, Brian A Menegaz, Vandhana Ramamoorthy, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Cancer
|
December 9, 2020
Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma
Mrinal M Gounder, Priscilla Merriam, Ravin Ratan, et al.
Rare Tumors
|
August 6, 2024
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort
Michael S Nakazawa, J Andrew Livingston, Maria A Zarzour, et al.
Practical Radiation Oncology
|
January 24, 2026
Outcomes Following Combined Modality Treatment to the Primary Site in Select Patients With Metastatic Soft Tissue Sarcoma
Andrew J Arifin, Andrew J Bishop, Devarati Mitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2023
Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes
Ryan A Denu, Richard K Yang, Alexander J Lazar, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 2023
SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection
Ahsan S Farooqi, Alison K Yoder, Heather Y Lin, et al.
Cancers
|
March 13, 2024
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?
Prapassorn Thirasastr, Thomas L Sutton, Cissimol P Joseph, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
April 25, 2025
Building a pre-surgical multiparametric-MRI-based morphologic, qualitative, semiquantitative, first and high-order radiomic predictive treatment response model for undifferentiated pleomorphic sarcoma to replace RECIST
Raul F Valenzuela, Elvis Duran-Sierra, Mathew Antony, et al.
Cancers
|
May 11, 2024
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience
Lewis F Nasr, Marianne Zoghbi, Rossana Lazcano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2022
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)
Justin T Moyers, Roberto Carmagnani Pestana, Jason Roszik, et al.
Journal of the National Cancer Institute
|
September 1, 2016
IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma
Salah-Eddine Lamhamedi-Cherradi, Brian A Menegaz, Vandhana Ramamoorthy, et al.
Page
of 6